Fidelity Investments
AXDX

Fidelity Investments’s Accelerate Diagnostics AXDX Stock Holding History

Fidelity Investments’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-301
Closed -$5K – 5347
2022
Q3 		$5K Sell
301
-36
-11% -$596 ﹤0.01% 4292
2022
Q2 		$3K Buy
337
+272
+418% +$2.4K ﹤0.01% 4429
2022
Q1 		$1K Buy
+65
New +$1.85K ﹤0.01% 4759
2021
Q1 		– Sell
-143,801
Closed -$10.9M – 3965
2020
Q4 		$10.9M Buy
143,801
+853
+0.6% +$76.4K ﹤0.01% 1943
2020
Q3 		$15.2M Sell
142,948
-3,214
-2% -$446K ﹤0.01% 1682
2020
Q2 		$22.2M Sell
146,162
-26,021
-15% -$2.57M ﹤0.01% 1507
2020
Q1 		$14.3M Sell
172,183
-24,007
-12% -$3.38M ﹤0.01% 1546
2019
Q4 		$33.2M Buy
196,190
+75,423
+62% +$12.4M ﹤0.01% 1392
2019
Q3 		$22.4M Buy
120,767
+3,769
+3% +$728K ﹤0.01% 1529
2019
Q2 		$26.8M Buy
116,998
+31,291
+37% +$6.12M ﹤0.01% 1505
2019
Q1 		$18M Buy
85,707
+11,862
+16% +$2.22M ﹤0.01% 1643
2018
Q4 		$8.49M Buy
73,845
+14,810
+25% +$2.19M ﹤0.01% 1858
2018
Q3 		$13.5M Buy
59,035
+10,385
+21% +$2.3M ﹤0.01% 1843
2018
Q2 		$10.8M Buy
48,650
+24,060
+98% +$5.38M ﹤0.01% 1923
2018
Q1 		$5.62M Buy
24,590
+337
+1% +$88.5K ﹤0.01% 2127
2017
Q4 		$6.35M Sell
24,253
-18,917
-44% -$4.43M ﹤0.01% 2102
2017
Q3 		$9.69M Buy
43,170
+1,163
+3% +$286K ﹤0.01% 1946
2017
Q2 		$11.5M Buy
42,007
+12,007
+40% +$3.25M ﹤0.01% 1900
2017
Q1 		$7.26M Buy
+30,000
New +$6.85M ﹤0.01% 2071
2016
Q2 		– Sell
-39,000
Closed -$5.6M – 2652
2016
Q1 		$5.6M Sell
39,000
-20,000
-34% -$2.82M ﹤0.01% 2126
2015
Q4 		$12.7M Buy
+59,000
New +$10.8M ﹤0.01% 1888

Other funds holding AXDX

GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Fidelity Investments's AXDX Position: Q4 2022 in Review

Fidelity Investments sold out of Accelerate Diagnostics (AXDX) in Q4 2022, closing a stake of 301 shares — an estimated $5K sold.

Fidelity Investments first reported a position in AXDX in Q4 2015 and held it in 21 quarters. The position peaked at $33.2M in Q4 2019. 73 funds tracked by Wall St. Rank hold AXDX as of Q4 2022.

  • Fidelity Investments reported no remaining Accelerate Diagnostics position as of Q4 2022 after selling out during the quarter.
  • Fidelity Investments sold 301 Accelerate Diagnostics shares in Q4 2022, an estimated $5K.
  • Fidelity Investments first reported a position in Accelerate Diagnostics in Q4 2015 and held it in 21 quarters.
  • Fidelity Investments's Accelerate Diagnostics position peaked at $33.2M in Q4 2019.
  • 73 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q4 2022.

Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.